Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 56,430 | 57,356 | 48,858 | 26,225 | 43,347 |
| Cost of Goods | 34,900 | 30,878 | 27,540 | 17,400 | 23,285 |
| Gross Profit | 21,530 | 26,478 | 21,318 | 8,825 | 20,062 |
| Operating Expenses | 33,426 | 29,887 | 25,862 | 20,720 | 23,307 |
| Operating Income | -10,996 | -2,531 | -4,004 | -11,495 | -2,960 |
| Interest Expense | 0 | 239 | 305 | 361 | 58 |
| Other Income | -650 | -175 | -88 | -107 | 181 |
| Pre-tax Income | -11,646 | -2,945 | -4,397 | -11,963 | -2,837 |
| Income Tax | -164 | 111 | 89 | 58 | 119 |
| Net Income Continuous | -11,482 | -3,056 | -4,486 | -12,021 | -2,956 |
| Net Income | $-11,482 | $-3,056 | $-4,486 | $-12,021 | $-2,956 |
| EPS Basic Total Ops | -4,375.00 | -1,250.00 | -1,875.00 | -5,636.42 | -1,434.16 |
| EPS Basic Continuous Ops | -4,380.04 | -1,187.74 | -1,834.02 | -5,611.22 | -1,388.25 |
| EPS Diluted Total Ops | -4,375.00 | -1,250.00 | -1,875.00 | -5,636.42 | -1,434.16 |
| EPS Diluted Continuous Ops | -4,380.04 | -1,187.74 | -1,834.02 | -5,611.22 | -1,388.25 |
| EBITDA(a) | $-10,019 | $-1,884 | $-3,132 | $-10,318 | $-1,516 |